Literature DB >> 31714957

Thrombotic thrombocytopenic purpura and defective apoptosis due to CASP8/10 mutations: the role of mycophenolate mofetil.

F Fioredda1, E Cappelli1, A Mariani1, A Beccaria1, E Palmisani1, A Grossi2, I Ceccherini2, R Venè3, C Micalizzi1, M Calvillo1, F Pierri1, I Mancini4, F Peyvandi5,6, F Corsolini7, C Dufour1, M Miano1.   

Abstract

Entities:  

Year:  2019        PMID： 31714957      PMCID： PMC6855129          DOI： 10.1182/bloodadvances.2019000575

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  25 in total

Review 1.  Splenectomy for the treatment of thrombotic thrombocytopenic purpura.

Authors:  M C Kappers-Klunne; P Wijermans; R Fijnheer; A J Croockewit; B van der Holt; J T M de Wolf; B Löwenberg; A Brand
Journal:  Br J Haematol       Date:  2005-09       Impact factor: 6.998

Review 2.  The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura.

Authors:  Wendy Lim; Sara K Vesely; James N George
Journal:  Blood       Date:  2015-01-08       Impact factor: 22.113

3.  Mycophenolate mofetil and Sirolimus as second or further line treatment in children with chronic refractory Primitive or Secondary Autoimmune Cytopenias: a single centre experience.

Authors:  Maurizio Miano; Maria Scalzone; Katia Perri; Elena Palmisani; Ilaria Caviglia; Concetta Micalizzi; Johanna Svahn; Michaela Calvillo; Laura Banov; Paola Terranova; Tiziana Lanza; Carlo Dufour; Francesca Fioredda
Journal:  Br J Haematol       Date:  2015-06-08       Impact factor: 6.998

Review 4.  Consequences of B-cell-depleting therapy: hypogammaglobulinemia and impaired B-cell reconstitution.

Authors:  Keith A Sacco; Roshini S Abraham
Journal:  Immunotherapy       Date:  2018-03-23       Impact factor: 4.196

Review 5.  Research and therapeutics-traditional and emerging therapies in systemic lupus erythematosus.

Authors:  Laurie S Davis; Andreas M Reimold
Journal:  Rheumatology (Oxford)       Date:  2017-04-01       Impact factor: 7.580

6.  Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy.

Authors:  Bérangère S Joly; Alain Stepanian; Thierry Leblanc; David Hajage; Hervé Chambost; Jérôme Harambat; Fanny Fouyssac; Vincent Guigonis; Guy Leverger; Tim Ulinski; Thérésa Kwon; Chantal Loirat; Paul Coppo; Agnès Veyradier
Journal:  Lancet Haematol       Date:  2016-10-03       Impact factor: 18.959

7.  Single Nucleotide Polymorphisms in Selected Apoptotic Genes and BPDE-Induced Apoptotic Capacity in Apparently Normal Primary Lymphocytes: A Genotype-Phenotype Correlation Analysis.

Authors:  Zhibin Hu; Chunying Li; Kexin Chen; Li-E Wang; Erich M Sturgis; Margaret R Spitz; Qingyi Wei
Journal:  J Cancer Epidemiol       Date:  2008-10-29

8.  Rituximab-based immunosuppression for autoimmune haemolytic anaemia in infants.

Authors:  Johanna Svahn; Francesca Fioredda; Michaela Calvillo; Angelo C Molinari; Concetta Micalizzi; Laura Banov; Madalina Schmidt; Daniela Caprino; Doretta Marinelli; Domenico Gallisai; Carlo Dufour
Journal:  Br J Haematol       Date:  2009-02-04       Impact factor: 6.998

9.  Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency.

Authors:  Hyung J Chun; Lixin Zheng; Manzoor Ahmad; Jin Wang; Christina K Speirs; Richard M Siegel; Janet K Dale; Jennifer Puck; Joie Davis; Craig G Hall; Suzanne Skoda-Smith; T Prescott Atkinson; Stephen E Straus; Michael J Lenardo
Journal:  Nature       Date:  2002-09-26       Impact factor: 49.962

Review 10.  How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome.

Authors:  Marie Scully; Tim Goodship
Journal:  Br J Haematol       Date:  2014-01-06       Impact factor: 6.998
View more
  1 in total

1.  Targeted NGS Yields Plentiful Ultra-Rare Variants in Inborn Errors of Immunity Patients.

Authors:  Alice Grossi; Maurizio Miano; Marina Lanciotti; Francesca Fioredda; Daniela Guardo; Elena Palmisani; Paola Terranova; Giuseppe Santamaria; Francesco Caroli; Roberta Caorsi; Stefano Volpi; Marco Gattorno; Carlo Dufour; Isabella Ceccherini
Journal:  Genes (Basel)       Date:  2021-08-24       Impact factor: 4.096
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.